208 related articles for article (PubMed ID: 8793703)
21. Difference between clinic and daytime blood pressure is not a measure of the white coat effect.
Parati G; Ulian L; Santucciu C; Omboni S; Mancia G
Hypertension; 1998 May; 31(5):1185-9. PubMed ID: 9576133
[TBL] [Abstract][Full Text] [Related]
22. Ambulatory blood pressure monitoring in the elderly hypertensive patient.
Torriani S; Waeber B; Petrillo A; Di Stefano R; Mooser V; Scherrer U; Nussberger J; Hofstetter JR; Brunner HR
J Hypertens Suppl; 1988 Nov; 6(1):S25-7. PubMed ID: 3216238
[TBL] [Abstract][Full Text] [Related]
23. Ambulatory blood pressure is still elevated in treated hypertensive diabetic subjects compared with untreated diabetic subjects with the same office blood pressure.
Chau NP; Bauduceau B; Vilar J; Gautier D
J Hum Hypertens; 1992 Apr; 6(2):91-4. PubMed ID: 1597851
[TBL] [Abstract][Full Text] [Related]
24. Experience with noninvasive ambulatory 24-hour blood pressure recording in a community hospital.
van de Weijgert EJ; Braun JJ
Neth J Med; 1992 Apr; 40(3-4):175-82. PubMed ID: 1603208
[TBL] [Abstract][Full Text] [Related]
25. Measurements of blood pressure with various techniques in daily practice: uncertainty in diagnosing office hypertension with short-term in-hospital registration of blood pressure.
Braun HJ; Rabouw H; Werner H; van Montfrans GA; de Stigter C; Zwinderman AH
Blood Press Monit; 1999 Apr; 4(2):59-64. PubMed ID: 10450115
[TBL] [Abstract][Full Text] [Related]
26. Calcium supplementation in patients with essential hypertension: assessment by office, home and ambulatory blood pressure.
Kawano Y; Yoshimi H; Matsuoka H; Takishita S; Omae T
J Hypertens; 1998 Nov; 16(11):1693-9. PubMed ID: 9856371
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
Lacourcière Y; Asmar R
Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
[TBL] [Abstract][Full Text] [Related]
28. Comparison of ambulatory and clinic blood pressure and heart rate in older persons with isolated systolic hypertension.
Rutan GH; McDonald RH; Kuller LH
Am J Hypertens; 1992 Dec; 5(12 Pt 1):880-6. PubMed ID: 1285937
[TBL] [Abstract][Full Text] [Related]
29. Twenty-four-hour blood pressure load as a surrogate end-point in assessing antihypertensive therapy.
White WB; Lund-Johansen P; Omvik P
J Hypertens Suppl; 1993 Jun; 11(4):S75-80. PubMed ID: 8377035
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the white-coat effect.
Gerin W; Ogedegbe G; Schwartz JE; Chaplin WF; Goyal T; Clemow L; Davidson KW; Burg M; Lipsky S; Kentor R; Jhalani J; Shimbo D; Pickering TG
J Hypertens; 2006 Jan; 24(1):67-74. PubMed ID: 16331103
[TBL] [Abstract][Full Text] [Related]
31. Blood-pressure control in the hypertensive population.
Mancia G; Sega R; Milesi C; Cesana G; Zanchetti A
Lancet; 1997 Feb; 349(9050):454-7. PubMed ID: 9040574
[TBL] [Abstract][Full Text] [Related]
32. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
33. Level of blood pressure control in a hypertensive population when measurements are performed outside the clinical setting.
Félix-Redondo FJ; Fernández-Bergés D; Espinosa-Garcia J; Pozuelos-Estrada J; Molina-Martínez LM; Pérez-Castán JF; Ríos-Rivera J; Valiente-Rubio JI; Gómez-de-la-Cámara A; Rodríguez-Pascual N
Cardiol J; 2009; 16(1):57-67. PubMed ID: 19130417
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
[TBL] [Abstract][Full Text] [Related]
35. Permanent blood pressure control over the 24 h by trandolapril.
Omboni S; Ravogli A; Villani A; Mancia G
Am J Hypertens; 1995 Oct; 8(10 Pt 2):71S-74S. PubMed ID: 8845088
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of blood pressure control outside the medical setting.
Banegas JR; Segura J; Sobrino J; Rodríguez-Artalejo F; de la Sierra A; de la Cruz JJ; Gorostidi M; Sarría A; Ruilope LM;
Hypertension; 2007 Jan; 49(1):62-8. PubMed ID: 17075026
[TBL] [Abstract][Full Text] [Related]
37. Ambulatory monitoring uncorrected for placebo overestimates long-term antihypertensive action. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators.
Staessen JA; Thijs L; Bieniaszewski L; O'Brien ET; Palatini P; Davidson C; Dobovisek J; Jääskivi M; Laks T; Lehtonen A; Vanhanen H; Webster J; Fagard R
Hypertension; 1996 Mar; 27(3 Pt 1):414-20. PubMed ID: 8698447
[TBL] [Abstract][Full Text] [Related]
38. Twenty-four-hour ambulatory blood pressure evaluation of antihypertensive agents.
Zanchetti A
J Hypertens Suppl; 1997 Dec; 15(7):S21-5. PubMed ID: 9532517
[TBL] [Abstract][Full Text] [Related]
39. Effect of placebo on 24-h non-invasive ambulatory blood pressure.
Mutti E; Trazzi S; Omboni S; Parati G; Mancia G
J Hypertens; 1991 Apr; 9(4):361-4. PubMed ID: 1646263
[TBL] [Abstract][Full Text] [Related]
40. White-coat effect in normotension and hypertension.
Zakopoulos NA; Kotsis VT; Pitiriga VCh; Toumanidis ST; Lekakis JP; Nanas SN; Vemmos KN; Stamatelopoulos SF; Moulopoulos SD
Blood Press Monit; 2002 Oct; 7(5):271-6. PubMed ID: 12409886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
